Navigation Links
Reportlinker Adds Microscopy Market in Latin America
Date:4/5/2011

RCE MICROSCOPE MARKET, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)

22 LATAM: OTHER MICROSCOPY INSTRUMENTS MARKET, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)

23 LATAM: MICROSCOPY MARKET, BY END-USERS, 2008 – 2015 ($THOUSAND)

24 LATAM: MICROSCOPY MARKET FOR ACADEMIC RESEARCH, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)

25 LATAM: MICROSCOPY MARKET FOR PHARMA & BIOTECH INDUSTRY, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)

26 LATAM: MICROSCOPY MARKET FOR RESEARCH INSTITUTIONS & LABORATORIES, BY GEOGRAPHY, 2008 – 2015 ($THOUSAND)

27 CARL ZEISS: TOTAL REVENUES, R&D EXPENSES ($THOUSAND)

28 CARL ZEISS: TOTAL REVENUES, BY GEOGRAPHY ($THOUSAND)

29 FEI COMPANY – TOTAL REVENUES AND R&D EXPENSES ($MILLION)

30 FEI COMPANY – TOTAL REVENUES BY SEGMENT ($MILLION)

31 HITACHI -TOTAL REVENUES & R&D EXPENDITURE ($THOUSAND)

32 HITACHI - TOTAL REVENUES BY SEGMENT ($THOUSAND)

33 JEOL – TOTAL REVENUES AND R&D EXPENDITURE ($MILLION)

34 JEOL – TOTAL REVENUES BY SEGMENT ($MILLION)

35 JEOL – TOTAL REVENUES BY GEOGRAPHY ($MILLION)

36 NIKON - TOTAL REVENUES AND R&D EXPENDITURE ($THOUSAND)

37 NIKON - TOTAL REVENUES BY SEGMENT ($THOUSAND)

38 NIKON - TOTAL REVENUES BY GEOGRAPHY ($THOUSAND)

39 OLYMPUS-TOTAL REVENUES AND R&D EXPENSE ($MILLION)

40 OLYMPUS- TOTAL REVENUES BY SEGMENT ($MILLION)

41 OLYMPUS- TOTAL REVENUES BY GEOGRAPHY ($MILLION)

LIST OF FIGURES

1 ADVANCED MICROSCOPY MARKET REVENUE IN LATAM, 2008 – 2015 ($MILLION)

2 LATAM MICROSCOPY MARKET (2010 VS. 2015)

3 LATAM MICROSCOPY – END-USER MARKET (2010)

4 NANOTECHNOLOGY RESEARCH PROFILE IN LATAM (2007)

5 R&D EXPENDITUREIN LATAM (2007)

6 CLINICAL TRIALS IN MAJOR MARKETS OF LATAM (2006 – 2010)

7 IMPACT OF KEY MARKET DRIVERS & RESTRAINTS

8
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Reportlinker Adds Leading Anti-Cancer Drugs: World Market Prospects 2011-2021
2. Reportlinker Adds Transdermal Drug Delivery - Technologies, Markets, and Companies
3. Reportlinker Adds World Anti-Obesity Drug Market 2011-2021
4. Reportlinker Adds World Biological Drugs Market 2011-2021
5. Reportlinker Adds World Influenza Vaccines Market 2011-2021
6. Reportlinker Adds Drug Delivery in Cancer - technologies, markets and companies
7. Reportlinker Adds Enzymes in Drug Manufacturing
8. Reportlinker Adds Personalized Medicine - Scientific & Commercial Aspects
9. Reportlinker Adds Pain Therapeutics - Drugs, Markets and Companies
10. Reportlinker Adds Molecular Diagnostics in Infectious Disease Testing
11. Reportlinker Adds Top 500 Pharmaceuticals Industry Report (Global)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... SAN DIEGO , July 1, 2015  AVACEN, Inc. ... a second AVACEN patent covering the medical technology platform supporting ... Logo - http://photos.prnewswire.com/prnh/20150630/227364LOGO ... The apparatus and methods patent no. 9,066,781 - Methods And ... devices manufactured by AVACEN and specific methods of use, referred ...
(Date:7/1/2015)... July 1, 2015   Continental Clinical Solutions (Continental) announced it is expanding its ... to accommodate increased volume in clinical studies and demand for unique patient populations.  ... ... ... ...
(Date:7/1/2015)... 2015  BioPharmX Corporation (NYSE MKT: BPMX) today announced ... of 3,636,364 shares of its common stock at a ... has granted the underwriters a 30-day option to purchase ... the public offering price. In addition, Korea ... has agreed to purchase 1,081,081 shares of common stock ...
Breaking Medicine Technology:AVACEN Medical Patent Issued 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 2Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 3Continental Clinical Solutions CEO Saleh Stevens Eyes Growth 4BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 2BioPharmX Corporation Closes Underwritten Public Offering of Common Stock 3
... Solutions Development Company (MSDC), a drug discovery and ... metabolic diseases, announced today that it has launched ... second drug candidate for the treatment of type ... placebo-controlled clinical trial will involve approximately 125 patients ...
... SAN and NYSE: SNY ) announced today ... Rights (CVRs) offered to Genzyme shareholders as part of ... by the U.S. Securities and Exchange Commission. ... Genzyme, sanofi-aventis has commenced an exchange offer to acquire ...
Cached Medicine Technology:Metabolic Solutions Development Company Launches Phase 2a Trial of Its Second Compound to Treat Type 2 Diabetes 2Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective 2Sanofi-aventis Announces Registration Statement for CVR Related to Genzyme Acquisition Declared Effective 3
(Date:7/1/2015)... ... 2015 , ... OncLive® will team with ... as it further expands its Strategic Alliance Partnership Program for raising awareness of ... OncLive’s editorial and marketing teams will collaborate with Sarah Cannon to share the ...
(Date:7/1/2015)... ... July 01, 2015 , ... The 28th annual Charity Horse Show hosted by ... 2015, at 6 p.m. in Pugh Bourne Park, 343 Oakfield Road. The event will ... zoo, an Elvis impersonator, a silent auction and concessions. , Horses and riders from ...
(Date:7/1/2015)... ... July 01, 2015 , ... ... author Lisa Stolzenberg, a Professor in FIU’s School of International and Public Affairs. ... 17 years who participated in the National Survey on Drug Use and Health, ...
(Date:7/1/2015)... ... 01, 2015 , ... Element Blue ™, a leading ... it has received trademark protection for its SensorInsight® computer software platform. SensorInsight® is ... multiple sources providing an environment where users can view and compare real-time and ...
(Date:7/1/2015)... ... July 01, 2015 , ... Bunion Bootie, the newest ... purchasing two or more Bunion Booties directly from their website, http://www.BunionBootie.com ... corrects misaligned toes and its ultra thin properties allow for protection against rubbing ...
Breaking Medicine News(10 mins):Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 2Health News:OncLive® Welcomes Sarah Cannon Cancer Network to Its Strategic Alliance Partnership Program 3Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 2Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 3Health News:Element Blue Receives Trademark Protection from U.S. Patent and Trademark Office for Its Award Winning SensorInsight® Software 4Health News:Bunion Bootie, the #1 Non-Surgical Treatment for Bunion Pain, Announces Their Big Summer Sale 2
... Creates Explosive Growth for Domestic and, International ... Reach $5.974 Billion With ... ANGELES, May 20 With another sweltering summer,forecast for ... are,driving growth in the burgeoning, multi-billion dollar bottled water,industry ...
... wins multi-million dollar, multi-year technology ... Medical Center, Biloxi, MS, HOUSTON, May 20 Shipcom ... announced today,that they have been selected by the Air Force ... across the Air Force Medical,Service and then pilot RFID systems ...
... Patients the Ability to Share their Prescription History, ... Drug,Stores Corporation (NYSE: LDG ) announced today ... platform for sharing of information between,patients and providers. ... the first,pharmacies to provide their customers with the ...
... TX According to the 2000 census, Americans office ... at their desks or work stations. Many recent studies ... longer hours in office environments, often under artificial light ... stress levels. , How can employers make office environments ...
... May 19 Six years ago,Senator Patty Murray ... and invest federal funding in the research critically ... mesothelioma, and,other asbestos related diseases. Since 2002, the ... with Senator,Murray to stop the death and suffering ...
... Standard Therapy for Eradicating H. pylori , An ... and standard triple therapies in patients with documented, ... sequential therapy appears superior to standard triple therapy ... Authors say if further trials confirm these findings, ...
Cached Medicine News:Health News:H2O = Big Business in a Bottle 2Health News:H2O = Big Business in a Bottle 3Health News:H2O = Big Business in a Bottle 4Health News:H2O = Big Business in a Bottle 5Health News:H2O = Big Business in a Bottle 6Health News:H2O = Big Business in a Bottle 7Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 2Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 3Health News:US Air Force Medical Service Selects Shipcom Wireless for Major Healthcare RFID Contract 4Health News:Longs Drugs Partners With Google on the Launch of Google Health 2Health News:Greener offices make happier employees 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 2Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 3Health News:Fighting Cancer: Historic Anti-Asbestos Legislation Moving Forward With Support of Meso Foundation 4
The new ProteomeX Workstation enables the rapid set up, execution and analysis of multidimensional LC/MS methods, providing you with the best possible technique to characterize your complex proteomic...
... over a wide range of concentration, ... more thorough characterization than other methods. ... relative change in the distribution of ... to measure heterogeneity, stoichiometry and self-associating ...
Storage temperature: 2 - 8C, linearity: 0 - 700 mg/dL, expected values: 30 - 780 mg/dL. Available with calibrator and number of tests 110....
Intended for the quantitative determination of triglycerides in serum or plasma. Reaction: endpoint, reaction is complete in five minutes at 37C. Wavelength: 540 nm. Linearity: 1000 mg/dL (11.3 mmol/...
Medicine Products: